Skip to main content

Table 6 Number of daily rapid-acting insulin injections, biphasic or glargine insulin and total daily insulin dose after the end of the monitoring period

From: Intensification of insulin therapy in patients with type 2 diabetes: a retrospective, non- interventional cohort study of patients treated with insulin glargine or biphasic human insulin in daily clinical practice

 

Control group

Active group

p-value

Number of insulin injections, n (%)

   

1

16 (10.1)

45 (31.7)

2

85 (53.5)

20 (14.1)

3

58 (36.5)

27 (19.0)

<0.001

4

0 (0.0)

49 (34.5)

 

5

0 (0.0)

1 (0.7)

Mean ± SD daily units of rapid acting insulin (U/day)

9.5 ± 2.3

23.3 ± 18.4

<0.001

Mean ± SD daily units of rapid acting insulin (U/Kg/day)

0.12 ± 0.03

0.29 ± 0.23

<0.001